Globe Life CEO sells 4,663 shares after option exercise
Globe Life Inc. Co-Chairman & CEO James Matthew Darden reported an option exercise and related share sale in company stock.
Rhea-AI Filing Summary
Globe Life Inc. Co-Chairman & CEO James Matthew Darden reported an option exercise and related share sale in company stock. On April 28, 2026, he exercised 4,663 Employee Stock Options at $100.74 per share and acquired the same number of common shares.
The same day, he executed an open-market sale of 4,663 common shares at an average price of about $153.88 per share, with sale prices ranging from $153.635 to $154.24. Following these transactions, he holds 58,451.4598 common shares directly and 4,185.5150 common shares indirectly through a 401(k) plan. He also retains 22,019 stock options after the exercise.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 4,663 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,663 | $100.74 | $470K |
| Sale | Common Stock | 4,663 | $153.8773 | $718K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- F2. Sales at prices ranging from $153.635 per share to $154.24 per share.
Key Figures
Key Terms
open-market sale financial
Employee Stock Option (Right to Buy) financial
derivative security financial
401(k) Plan financial
FAQ
What insider transactions did Globe Life (GL) CEO report on April 28, 2026?
What stock options did the Globe Life (GL) CEO exercise in this Form 4?
Does the Globe Life (GL) CEO still hold stock options after this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.